Real-time diagnostics during surgery and in vivo monitoring of chemotherapy-induced tissue changes are two critical technologies in cancer treatments, which would enable individualized surgical treatment. However, none of the available surgical techniques, such as “iKnife” and Fluorescent bioelectricity reporter (FBR) can be currently used in clinical setting.
New technology developed by a team in Imperial college London measures voltage in tissue to differentiate cancerous from non-cancerous tissue in real-time. This method paves way for the development of predictive and prognostic biomarkers based on the biopotential properties of cancerous tissue. It could potentially be used as a portable theatre instrument that would enable testing of wide range of cancerous tissue samples during operation.
+44 (0)20 7594 6867